Use and monitoring of low dose rituximab in myasthenia gravis

No Thumbnail Available
File version
Author(s)
Blum, Stefan
Gillis, David
Brown, Helen
Boyle, Richard
Henderson, Robert
Heyworth-Smith, David
Hogan, Patrick
Kubler, Paul
Lander, Cecilie
Limberg, Nicole
Pillans, Peter
Prain, Kerri
Staples, Christopher
Walsh, Michael
McCombe, Pamela
Wong, Richard
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2011
Size
File type(s)
Location
License
Abstract

Background Myasthenia gravis is an autoimmune disorder of the neuromuscular junction. Rituximab (RTX), a monoclonal antibody to CD20, leads to B lymphocyte depletion and has been used in some autoimmune disorders, including small case series of myasthenia gravis patients. Methods A retrospective analysis was performed of all patients with acetylcholine receptor (AChR) (11 subjects) or muscle specific kinase antibody (MuSK) positive myasthenia gravis (three subjects), who had been treated with RTX in Brisbane, Australia. In most patients 1 g of RTX, in two divided doses, was given. Patients were monitored by serial clinical assessments, flow cytometry of peripheral blood B lymphocytes and antibody testing. Results RTX led to a significant improvement in symptoms in 11 of 14 patients. Doses of immunosuppressive medications were able to be reduced in 12 of 14 patients but medications could be completely ceased in only one patient. A demonstrable reduction of autoantibody levels was found in only three AChR positive patients and one MuSK positive patient, independent of clinical improvement. Peripheral blood B lymphocyte depletion was achieved in 13 out of 14 patients. B lymphocyte recovery occurred between 9 and 30 months post RTX (median 12.3 months) and was consistently associated with worsening of clinical symptoms. Conclusion Rituximab at a dose of 1 g appears to be beneficial in the treatment of patients with severe myasthenia gravis. Serial monitoring of peripheral blood B lymphocytes appears to be useful in guiding the need for further RTX therapy.

Journal Title

Journal of Neurology, Neurosurgery and Psychiatry

Conference Title
Book Title
Edition
Volume

2011

Issue

82

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Medical and Health Sciences not elsewhere classified

Medical and Health Sciences

Psychology and Cognitive Sciences

Persistent link to this record
Citation
Collections